Singapore: Industrial Production disappointed in June

Alvin Liew, Senior Economist at UOB Group, reviews the latest Industrial Production figures in Singapore.

Key Takeaways

“Singapore’s industrial production (IP) came in below expectations in Jun as it declined by 8.5% m/m SA, which translated to a weaker growth of 2.2% y/y, the lowest since Jan 2022 (from the revised May readings of 9.2% m/m, 10.4% y/y and fell short of Bloomberg survey estimates.”

“The main sources of IP growth were unchanged from May, but transport engineering took the lead in driving IP growth while electronics output growth eased markedly following a surprise 2.6% y/y fall in semiconductor. The other growth segments were general manufacturing and precision engineering, more than offsetting the continued weakness in biomedical (of which pharmaceuticals production plunged -24.9% y/y) and chemicals (of which petrochemicals remained the main drag).”

“Based on advance estimates released by Ministry of Trade and Industry on 14 Jul, Singapore’s economy grew by 4.8% y/y in 2Q with contribution for all the three major sectors including manufacturing which expanded by 8% y/y. However, based on the Jun IP report, the manufacturing sector is likely to have grown by less, at 5.7% y/y in 2Q. Assuming no major changes to the other sectors, we now expect 2Q’s GDP growth to be revised lower by 0.3ppt to 4.5% y/y, taking into account the lowered manufacturing expansion.”

“Singapore’s IP expanded 5.6% in the first half of 2022. We continue to be cautiously positive on the outlook for electronics, transport engineering, general manufacturing, and precision engineering, to drive overall IP growth but we are also cognizant there is an easing trend in sales since the peak in Jun 2021about the attendant external risks including (1) Russia-Ukraine conflict driving commodity prices higher, (2) global supply disruptions due to China’s zero-COVID policy, (3) monetary policy tightening stance in the advanced economies slowing growth and (4) resurgence of COVID-19 infections and/or new variants. In addition, another dampener to headline growth is the relatively higher base levels for the rest of 2022. We maintain our IP growth forecast at 4.5% in 2022 (from 13.2% in 2021) while our full year 2022 GDP growth forecast is also unchanged at 3.5%.”

Share: Feed news

Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.

If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.

FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.

The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.